Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M100907 + Escitalopram in Treatment Resistant Depression
NCT00070694Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of volinanserin in major depressive disorder (MDD), sponsored by National Institute of Mental Health. Started Sep 2003; status: completed.
02
Drugs
volinanserin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00070694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070694.